Market Overview - The hair medical concept sector declined by 1.01% as of the market close on August 22, ranking among the top decliners in concept sectors [1] - Major stocks in the sector that experienced significant declines include Shuiyang Co., Huabang Health, and Baicheng Pharmaceutical, while stocks that saw gains include Zhendong Pharmaceutical, Kangyuan Pharmaceutical, and International Medicine, with increases of 1.33%, 0.69%, and 0.37% respectively [1] Concept Sector Performance - The top-performing concept sectors today include: - China AI 50: +5.31% - National Big Fund Holdings: +5.00% - SMIC Concept: +3.67% - MCU Chips: +3.64% - Automotive Chips: +3.46% [2] - Conversely, the hair medical sector was among the worst performers, alongside soybean and high-pressure oxygen chamber sectors, which saw declines of 0.94% and 0.76% respectively [2] Capital Flow Analysis - The hair medical concept sector experienced a net outflow of 289 million yuan, with 15 stocks seeing net outflows and 10 stocks exceeding 10 million yuan in outflows [2] - The stock with the highest net outflow was Shuiyang Co., with a net outflow of 123.37 million yuan, followed by Kids King, Jiu Zhi Tang, and Kang En Bei with net outflows of 84.69 million yuan, 48.68 million yuan, and 23.36 million yuan respectively [2] - Stocks with the highest net inflows included Kangyuan Pharmaceutical, Zhendong Pharmaceutical, and Xianju Pharmaceutical, with net inflows of 42.76 million yuan, 31.16 million yuan, and 21.98 million yuan respectively [2][3] Individual Stock Performance - Notable declines in the hair medical sector include: - Shuiyang Co.: -4.82% with a turnover rate of 11.16% and a net outflow of 123.37 million yuan - Kids King: -0.16% with a turnover rate of 4.36% and a net outflow of 84.69 million yuan - Jiu Zhi Tang: -1.92% with a turnover rate of 5.92% and a net outflow of 48.68 million yuan [2] - Stocks with positive performance include: - Zhendong Pharmaceutical: +1.33% with a turnover rate of 6.15% and a net inflow of 31.16 million yuan - Kangyuan Pharmaceutical: +0.69% with a turnover rate of 4.39% and a net inflow of 42.76 million yuan [3]

Group 1 - The high-pressure oxygen chamber concept sector experienced a decline of 0.76%, ranking among the top declines in concept sectors as of the market close on August 22 [1] - Within the sector, major declines were observed in companies such as Samsung Medical, Aoyang Health, and Dahu Co., with notable increases in Hangyang Co., Yinkang Life, and International Medicine, which rose by 0.97%, 0.86%, and 0.37% respectively [1] Group 2 - The high-pressure oxygen chamber concept sector saw a net outflow of 260 million yuan in principal funds today, with six stocks experiencing net outflows [2] - The stock with the highest net outflow was Tiedao Heavy Industry, which had a net outflow of 143 million yuan, followed by Innovative Medical, Samsung Medical, and Aoyang Health with net outflows of 60.83 million yuan, 43.65 million yuan, and 13.12 million yuan respectively [2] - Conversely, the stocks with the highest net inflows included International Medicine, Jinling Pharmaceutical, and Yinkang Life, with net inflows of 3.35 million yuan, 3.27 million yuan, and 3.20 million yuan respectively [2]

Core Insights - International Medicine (000516.SZ) released its semi-annual report for 2025, indicating that as of August 21, 2025, six institutional investors held a total of 742 million shares, representing 33.14% of the company's total equity [1] - The institutional holding percentage decreased by 0.46 percentage points compared to the previous quarter [1] - Four public funds were disclosed this period, including Huatai-PineBridge Healthcare Active Growth One-Year Holding Mixed A, Golden Eagle Strategy Allocation Mixed, GF Asset Management Prosperity Selection Mixed A, and Zheshang Huijin Transformation Driven [1] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.29% compared to the previous quarter [1]

Group 1 - The company will not distribute cash dividends, issue bonus shares, or convert reserves into share capital for the reporting period [2] - The company approved a stock repurchase loan application of RMB 44.5 million from Bank of Communications Shaanxi Branch on April 8, 2025 [7] - The company increased its investment in Xi'an International Medical Center by RMB 380 million, raising its registered capital from RMB 1.4 billion to RMB 1.78 billion [7] Group 2 - The company held its 13th Board of Directors' sixth meeting on August 20, 2025, with all seven directors present [8] - The board approved the 2025 semi-annual report and its summary with unanimous consent [9] - The board proposed amendments to the company's articles of association and various governance rules, which require shareholder approval [10][12] Group 3 - The company announced the resignation of several board members due to governance structure adjustments following the revision of the Company Law [26] - The resigning members will continue to hold other positions within the company [27] - The company expressed gratitude for the contributions of the departing members during their tenure [28] Group 4 - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025, at 2:45 PM [30][31] - Shareholders can participate in the meeting through both on-site voting and online voting [33] - The deadline for shareholder registration is September 3, 2025 [34]

Core Viewpoint - The company International Medical reported a stable stock price of 5.46 yuan, with a slight fluctuation in trading, indicating a stable market position despite recent financial challenges [1]. Financial Performance - For the first half of 2025, the company achieved a revenue of 2.034 billion yuan, representing a year-on-year decline of 15.95% [1]. - The net profit attributable to shareholders was a loss of 165 million yuan, which is an improvement compared to a loss of 174 million yuan in the same period last year [1]. - The net cash flow from operating activities was 593 million yuan, showing a year-on-year increase of 12.75% [1]. Market Activity - On August 21, the company experienced a net outflow of main funds amounting to 2.7254 million yuan, with a cumulative net outflow of 29.5115 million yuan over the past five days [1]. Company Overview - International Medical operates in the healthcare services industry, focusing on health management and the application of modern medical technology [1]. - The company primarily runs Xi'an High-tech Hospital and Xi'an International Medical Center Hospital, providing diversified healthcare services through a model that combines medical care and elderly care [1]. Governance Changes - Some directors and supervisors of the company resigned due to adjustments in the governance structure resulting from amendments to the Company Law [1].

Group 1 - The company announced the resignation of key executives, including Wang Aiping, Cao Heling, and Cao Jianan, due to governance structure adjustments following the revision of the Company Law [3] - Wang Aiping and Cao Heling both resigned from their positions as directors and vice chairpersons, while Cao Jianan stepped down as the chairman of the supervisory board [3] - The revenue composition for the company in 2024 is projected to be 97.87% from the medical industry, 2.07% from other social services, 0.04% from software and information technology services, and 0.02% from commodity circulation [1]

（文章来源：每日经济新闻） 国际医学（SZ 000516，收盘价：5.46元）8月21日晚间发布半年度业绩报告称，2025年上半年营业收入 约20.34亿元，同比减少15.95%；归属于上市公司股东的净利润亏损约1.65亿元；基本每股收益亏损 0.073元。2024年同期营业收入约24.2亿元；归属于上市公司股东的净利润亏损约1.74亿元；基本每股收 益亏损0.0768元。 ...

西安国际医学投资股份有限公司 2025 年半年度财务报告 （未经审计） 2025 年 8 月 20 日 西安国际医学投资股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 | 编制单位：西安国际医学投资股份有限公司 | 2025 年 06 月 30 日（未经审计） | 单位：元 | | --- | --- | --- | | 项目 | 期末余额 | 期初余额 | | 流动资产： | | | | 货币资金 | 397,812,399.82 | 590,562,003.38 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | 15,335,398.00 | 89,074,177.50 | | 衍生金融资产 | | | | 应收票据 | | | | 应收账款 | 594,164,437.89 | 739,394,118.00 | | 应收款项融资 | | | | 预付款项 | 18,838,552.95 | 14,918,233.92 | | 应收保费 | ...

证券代码：000516 证券简称：国际医学 公告编号：2025-038 西安国际医学投资股份有限公司 关于召开2025年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、会议召开的基本情况 1.股东会届次：本次股东会是 2025 年第一次临时股东会。 2.召集人：西安国际医学投资股份有限公司董事会。 3.公司第十三届董事会第六次会议审议通过了关于召开公司 2025 年第一次 临时股东会的事项。会议的召开符合《公司法》《上市公司股东会规则》《股 票上市规则》等有关法律法规、规范性文件的规定和《公司章程》的要求。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025 年 9 月 8 日的交易时间，即 09:15—09:25，09:30—11:30 和 13:00— 15:00；通过深圳证券交易所互联网系统投票的具体时间为：2025 年 9 月 8 日 09:15—15:00 期间任意时间。 5.会议的召开方式：现场表决和网络投票相结合的方式。 公司将通过深圳证券交易所交易系统和互联网投票系统向全体股东提供网络 形式的投票平 ...

西安国际医学投资股份有限公司董事会于2025年8月11日以书面 方式发出召开公司第十三届董事会第六次会议的通知，并于2025年8 月20日在公司总部会议室以现场表决形式召开。会议应到董事7人， 实到董事7人，出席会议的董事有史今、刘旭、刘瑞轩、孙文国、师 萍、张宝通、李成，公司监事会成员列席了会议。会议的召开符合有 关法律、法规、规章和《公司章程》的规定。会议由史今董事长主持。 经会议认真审议和投票表决，通过了下述决议： 一、通过公司《2025 年半年度报告》及其摘要（7 票同意、0 票 反对、0 票弃权）； 二、通过《关于修改<公司章程>的议案》（7 票同意、0 票反对、 0 票弃权）； 为了进一步提高公司治理水平，根据《中华人民共和国公司法》、 中国证券监督管理委员会《上市公司章程指引》《深圳证券交易所股 票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主 板上市公司规范运作》等法律、行政法规、部门规章和规范性文件的 相关规定，结合公司的实际情况，同意对《公司章程》进行修改。 证券代码：000516 证券简称：国际医学 公告编号：2025-035 西安国际医学投资股份有限公司 第十三届董事会 ...